Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Pircher

Showing results (61-70 of 97) with videos related to

Pageof 10
Sort By:
Cancers|February 16, 2020
The Impact of Cand1 in Prostate CancerAndrea Eigentler, Piotr Tymoszuk, Johanna Zwick, et al.
Journal of Medicinal Chemistry|December 18, 2024
Eradication of Therapy-Resistant Cancer Stem Cells by Novel Telmisartan DerivativesAnna M Schoepf, Maximilian Gebhart, Martin Federspiel, et al.
Oncotarget|March 10, 2016
Biomarkers of evasive resistance predict disease progression in cancer patients treated with antiangiogenic therapiesAndreas Pircher, Karin Jöhrer, Florian Kocher, et al.
Lung Cancer (Amsterdam, Netherlands)|May 1, 2014
Neoadjuvant chemo-immunotherapy modifies CD4(+)CD25(+) regulatory T cells (Treg) in non-small cell lung cancer (NSCLC) patientsAndreas Pircher, Gabriele Gamerith, Arno Amann, et al.
Angiogenesis|September 7, 2017
Tumor vessel disintegration by maximum tolerable PFKFB3 blockadeLena-Christin Conradi, Aleksandra Brajic, Anna Rita Cantelmo, et al.
Translational Lung Cancer Research|October 21, 2024
Tumor immune microenvironment analysis of non-small cell lung cancer development through multiplex immunofluorescenceJiaping Zhao, Yu Lu, Zhaofeng Wang, et al.
Heliyon|May 1, 2024
Comparative analysis of 10X Chromium vs. BD Rhapsody whole transcriptome single-cell sequencing technologies in complex human tissuesStefan Salcher, Isabel Heidegger, Gerold Untergasser, et al.
Lung Cancer (Amsterdam, Netherlands)|July 27, 2021
Deregulated glutamate to pro-collagen conversion is associated with adverse outcome in lung cancer and may be targeted by renin-angiotensin-aldosterone system (RAS) inhibitionFlorian Kocher, Piotr Tymoszuk, Arno Amann, et al.
Cardiovascular Research|July 27, 2019
Liposomal doxorubicin attenuates cardiotoxicity via induction of interferon-related DNA damage resistanceMariann Gyöngyösi, Dominika Lukovic, Katrin Zlabinger, et al.
JTO Clinical and Research Reports|July 2, 2026
Trastuzumab Deruxtecan Induces Complete Pathological Response in Oligometastatic HER2-Mutant NSCLC: Case ReportLaurenz Nagl, Lena Horvath, Arno Amann, et al.
Pageof 10

Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
Cancers|February 16, 2020
The Impact of Cand1 in Prostate CancerAndrea Eigentler, Piotr Tymoszuk, Johanna Zwick, et al.
Journal of Medicinal Chemistry|December 18, 2024
Eradication of Therapy-Resistant Cancer Stem Cells by Novel Telmisartan DerivativesAnna M Schoepf, Maximilian Gebhart, Martin Federspiel, et al.
Oncotarget|March 10, 2016
Biomarkers of evasive resistance predict disease progression in cancer patients treated with antiangiogenic therapiesAndreas Pircher, Karin Jöhrer, Florian Kocher, et al.
Lung Cancer (Amsterdam, Netherlands)|May 1, 2014
Neoadjuvant chemo-immunotherapy modifies CD4(+)CD25(+) regulatory T cells (Treg) in non-small cell lung cancer (NSCLC) patientsAndreas Pircher, Gabriele Gamerith, Arno Amann, et al.
Angiogenesis|September 7, 2017
Tumor vessel disintegration by maximum tolerable PFKFB3 blockadeLena-Christin Conradi, Aleksandra Brajic, Anna Rita Cantelmo, et al.
Translational Lung Cancer Research|October 21, 2024
Tumor immune microenvironment analysis of non-small cell lung cancer development through multiplex immunofluorescenceJiaping Zhao, Yu Lu, Zhaofeng Wang, et al.
Heliyon|May 1, 2024
Comparative analysis of 10X Chromium vs. BD Rhapsody whole transcriptome single-cell sequencing technologies in complex human tissuesStefan Salcher, Isabel Heidegger, Gerold Untergasser, et al.
Lung Cancer (Amsterdam, Netherlands)|July 27, 2021
Deregulated glutamate to pro-collagen conversion is associated with adverse outcome in lung cancer and may be targeted by renin-angiotensin-aldosterone system (RAS) inhibitionFlorian Kocher, Piotr Tymoszuk, Arno Amann, et al.
Cardiovascular Research|July 27, 2019
Liposomal doxorubicin attenuates cardiotoxicity via induction of interferon-related DNA damage resistanceMariann Gyöngyösi, Dominika Lukovic, Katrin Zlabinger, et al.
JTO Clinical and Research Reports|July 2, 2026
Trastuzumab Deruxtecan Induces Complete Pathological Response in Oligometastatic HER2-Mutant NSCLC: Case ReportLaurenz Nagl, Lena Horvath, Arno Amann, et al.
Pageof 10